Cardiac amyloidosis: A practical approach to diagnosis and management

Prashant Kapoor, Thenappan Thenappan, Ekta Kapoor, Shaji K Kumar, Philip R. Greipp

Research output: Contribution to journalArticle

67 Citations (Scopus)

Abstract

Cardiac amyloidosis, the primary determinant of prognosis in systemic amyloidoses, is characterized by infiltration of myocardium by amyloid protein resulting in cardiomyopathy and conduction disturbances. Cardiac involvement is primarily encountered in immunoglobulin (AL) and transthyretin-associated (hereditary/familial and senile) amyloidoses. Although the latter variants could be indolent, untreated AL amyloidosis with clinical cardiac involvement is a rapidly fatal disease. The management decisions of cardiac amyloidosis are based on the underlying cause. Although treatment of senile systemic amyloidosis is largely supportive, the therapeutic approaches for AL amyloidosis include chemotherapy, autologous stem cell transplantation, and, rarely, cardiac transplantation. The familial variant is potentially curable with a liver ± cardiac transplantation. This narrative review outlines a practical approach to these challenging diagnoses in the face of rapidly evolving management strategies.

Original languageEnglish (US)
Pages (from-to)1006-1015
Number of pages10
JournalAmerican Journal of Medicine
Volume124
Issue number11
DOIs
StatePublished - Nov 2011

Fingerprint

Amyloidosis
Heart Transplantation
Familial Amyloidosis
Amyloidogenic Proteins
Prealbumin
Stem Cell Transplantation
Cardiomyopathies
Liver Transplantation
Immunoglobulins
Myocardium
Drug Therapy
Therapeutics

Keywords

  • AL
  • Amyloidosis
  • Cardiomyopathy
  • Familial
  • Heart failure
  • Hereditary
  • Light chain
  • Primary
  • Senile

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Cardiac amyloidosis : A practical approach to diagnosis and management. / Kapoor, Prashant; Thenappan, Thenappan; Kapoor, Ekta; Kumar, Shaji K; Greipp, Philip R.

In: American Journal of Medicine, Vol. 124, No. 11, 11.2011, p. 1006-1015.

Research output: Contribution to journalArticle

@article{a87e2155d10d4c24ab602d2695ef504e,
title = "Cardiac amyloidosis: A practical approach to diagnosis and management",
abstract = "Cardiac amyloidosis, the primary determinant of prognosis in systemic amyloidoses, is characterized by infiltration of myocardium by amyloid protein resulting in cardiomyopathy and conduction disturbances. Cardiac involvement is primarily encountered in immunoglobulin (AL) and transthyretin-associated (hereditary/familial and senile) amyloidoses. Although the latter variants could be indolent, untreated AL amyloidosis with clinical cardiac involvement is a rapidly fatal disease. The management decisions of cardiac amyloidosis are based on the underlying cause. Although treatment of senile systemic amyloidosis is largely supportive, the therapeutic approaches for AL amyloidosis include chemotherapy, autologous stem cell transplantation, and, rarely, cardiac transplantation. The familial variant is potentially curable with a liver ± cardiac transplantation. This narrative review outlines a practical approach to these challenging diagnoses in the face of rapidly evolving management strategies.",
keywords = "AL, Amyloidosis, Cardiomyopathy, Familial, Heart failure, Hereditary, Light chain, Primary, Senile",
author = "Prashant Kapoor and Thenappan Thenappan and Ekta Kapoor and Kumar, {Shaji K} and Greipp, {Philip R.}",
year = "2011",
month = "11",
doi = "10.1016/j.amjmed.2011.04.013",
language = "English (US)",
volume = "124",
pages = "1006--1015",
journal = "American Journal of Medicine",
issn = "0002-9343",
publisher = "Elsevier Inc.",
number = "11",

}

TY - JOUR

T1 - Cardiac amyloidosis

T2 - A practical approach to diagnosis and management

AU - Kapoor, Prashant

AU - Thenappan, Thenappan

AU - Kapoor, Ekta

AU - Kumar, Shaji K

AU - Greipp, Philip R.

PY - 2011/11

Y1 - 2011/11

N2 - Cardiac amyloidosis, the primary determinant of prognosis in systemic amyloidoses, is characterized by infiltration of myocardium by amyloid protein resulting in cardiomyopathy and conduction disturbances. Cardiac involvement is primarily encountered in immunoglobulin (AL) and transthyretin-associated (hereditary/familial and senile) amyloidoses. Although the latter variants could be indolent, untreated AL amyloidosis with clinical cardiac involvement is a rapidly fatal disease. The management decisions of cardiac amyloidosis are based on the underlying cause. Although treatment of senile systemic amyloidosis is largely supportive, the therapeutic approaches for AL amyloidosis include chemotherapy, autologous stem cell transplantation, and, rarely, cardiac transplantation. The familial variant is potentially curable with a liver ± cardiac transplantation. This narrative review outlines a practical approach to these challenging diagnoses in the face of rapidly evolving management strategies.

AB - Cardiac amyloidosis, the primary determinant of prognosis in systemic amyloidoses, is characterized by infiltration of myocardium by amyloid protein resulting in cardiomyopathy and conduction disturbances. Cardiac involvement is primarily encountered in immunoglobulin (AL) and transthyretin-associated (hereditary/familial and senile) amyloidoses. Although the latter variants could be indolent, untreated AL amyloidosis with clinical cardiac involvement is a rapidly fatal disease. The management decisions of cardiac amyloidosis are based on the underlying cause. Although treatment of senile systemic amyloidosis is largely supportive, the therapeutic approaches for AL amyloidosis include chemotherapy, autologous stem cell transplantation, and, rarely, cardiac transplantation. The familial variant is potentially curable with a liver ± cardiac transplantation. This narrative review outlines a practical approach to these challenging diagnoses in the face of rapidly evolving management strategies.

KW - AL

KW - Amyloidosis

KW - Cardiomyopathy

KW - Familial

KW - Heart failure

KW - Hereditary

KW - Light chain

KW - Primary

KW - Senile

UR - http://www.scopus.com/inward/record.url?scp=80054993331&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80054993331&partnerID=8YFLogxK

U2 - 10.1016/j.amjmed.2011.04.013

DO - 10.1016/j.amjmed.2011.04.013

M3 - Article

C2 - 22017778

AN - SCOPUS:80054993331

VL - 124

SP - 1006

EP - 1015

JO - American Journal of Medicine

JF - American Journal of Medicine

SN - 0002-9343

IS - 11

ER -